CSS LLC’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

CSS LLC’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,000	Closed	-$81K	–	1293
2022 Q1	$81K	Buy	+5,000	New	+$78.3K	﹤0.01%	960
2021 Q1	–	Sell	-3,647	Closed	-$102K	–	1100
2020 Q4	$90K	Buy	3,647 +1,083	+42%	+$35.9K	﹤0.01%	720
2020 Q3	$106K	Buy	+2,564	New	+$118K	0.01%	655
2020 Q1	–	Sell	-547	Closed	-$49.2K	–	793
2019 Q4	$68K	Buy	+547	New	+$49K	﹤0.01%	587
2019 Q2	–	Sell	-60	Closed	-$5.37K	–	876
2019 Q1	$7K	Buy	+60	New	+$6.56K	﹤0.01%	519
2018 Q1	–	Sell	-9,400	Closed	-$549K	–	634
2017 Q4	$549K	Buy	9,400 +900	+11%	+$56.8K	0.03%	335
2017 Q3	$493K	Buy	+8,500	New	+$916K	0.02%	356
2017 Q2	–	Sell	-3,200	Closed	-$371K	–	702
2017 Q1	$362K	Buy	+3,200	New	+$374K	0.02%	388

Other funds holding ICPT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

CSS LLC's ICPT Position: Q2 2022 in Review

CSS LLC sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2022, closing a stake of 5,000 shares — an estimated $81K sold.

CSS LLC first reported a position in ICPT in Q1 2017 and held it in 8 quarters. The position peaked at $549K in Q4 2017. 144 funds tracked by Wall St. Rank hold ICPT as of Q2 2022.

CSS LLC reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
CSS LLC sold 5,000 Intercept Pharmaceuticals, Inc. shares in Q2 2022, an estimated $81K.
CSS LLC first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2017 and held it in 8 quarters.
CSS LLC's Intercept Pharmaceuticals, Inc. position peaked at $549K in Q4 2017.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2022.

Based on CSS LLC's 13F filing for Q2 2022, filed 15 Aug 2022.